Fulminant Serratia marcescens Panophthalmitis.
Department of Ophthalmology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Ophthalmology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Hsiao-Pei
HP
Guo
Department of Ophthalmology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Ophthalmology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: tjw@tmu.edu.tw.
Tsung-Jen
TJ
Wang
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002443:Ceftriaxone / Q000008:administration & dosage; D003315:Cornea / Q000382:microbiology / Q000473:pathology*; D009877:Endophthalmitis / Q000175:diagnosis* / Q000382:microbiology; D005094:Exophthalmos / Q000382:microbiology; D005143:Eyelids / Q000382:microbiology / Q000473:pathology*; D005839:Gentamicins / Q000008:administration & dosage; D006801:Humans; D020300:Intracranial Hemorrhages; D008297:Male; D016868:Serratia Infections / Q000150:complications / Q000175:diagnosis*; D012706:Serratia marcescens; D014057:Tomography, X-Ray Computed; D014474:Unconsciousness
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002443:Ceftriaxone